Peptilex – The Peptide Encyclopedia
- 34 peptides – from semaglutide to BPC-157 – in one book
- An evidence grade (A–E) and the key studies for every peptide
- Where each one stands in 2026 – US, EU and Switzerland
Hormones & growth
Sermorelin
- Type
- GHRH analogue (first 29 amino acids of natural GHRH)
- Main use or focus
- Formerly: diagnosis and treatment of growth hormone deficiency in children. Today promoted for "anti-aging"
Key studies from the book
110 children with growth hormone deficiency; growth rate rose from 4.1 to 8.0 centimeters per year within six months.
Thorner M et al. – Journal of Clinical Endocrinology & Metabolism, 1996Randomized, 19 older adults, 16 weeks; IGF-1 and skin thickness up, lean mass up in men.
Khorram O et al. – Journal of Clinical Endocrinology & Metabolism, 199711 healthy older men, 6 weeks; growth hormone up, two of six strength measures improved.
Vittone J et al. – Metabolism, 1997
All key studies, risks and open questions are in the book.
Research at a glance
All papers25
Human studies18
Animal studies only0
Randomized trials0
Meta-analyses & systematic reviews0
Source: PubMed and ClinicalTrials.gov via the Peptilex study database
Go deeper
Full profile in the book
What it is, how it acts, the key studies, risks and open questions.
Registered trials
ClinicalTrials.gov · name in study title · ongoing first
No registered trial yet on ClinicalTrials.gov.
Latest key papers
PubMed · newest first
- 2006
Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?
ReviewWalker RF et al. · Clinical Interventions in AgingPMID 18046908